Literature DB >> 7466589

False aneurysms following arterial reconstruction.

B Satiani.   

Abstract

False aneurysms are increasingly being seen after the widespread utilization of arterial reconstructive surgical procedures involving implantation of prosthetic materials. The most common site of occurrence is the femoral location. The average interval between the primary procedure and the diagnosis of a false aneurysm in 42 months. THe exact cause remains uncertain, although multiple factors are most likely involved. these include degeneration of the host arterial wall, local endarterectomy, type of anastomosis, suture and graft material, various mechanical factors, hypertension and infection. Although small asymptomatic false aneurysms in easily accessible locations can be watched, a variety of complications, such as graft occlusion, rapid enlargement and rupture, venous and neural compression and distal embolization can occur. Early elective resection and repair are recommended in most patients.

Entities:  

Mesh:

Year:  1981        PMID: 7466589

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  False aneurysms after prosthetic reconstructions for aortoiliac obstructive disease.

Authors:  P J van den Akker; R Brand; R van Schilfgaarde; J H van Bockel; J L Terpstra
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

2.  Progress in the treatment of anastomotic aneurysms.

Authors:  R Courbier; R Aboukhater
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

3.  Femoral anastomotic false aneurysms. An 11-year experience analyzed with a case control study.

Authors:  J R Youkey; G P Clagett; N M Rich; R A Brigham; P M Orecchia; J M Salander
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

4.  A 10-year review of false aneurysms in Nottingham.

Authors:  D C Berridge; J J Earnshaw; G S Makin; B R Hopkinson
Journal:  Ann R Coll Surg Engl       Date:  1988-07       Impact factor: 1.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.